Prime Therapeutics unveils its Diversity, Equity and Inclusion Transparency Report

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

May 4, 2023

Prime Therapeutics (Prime) released its second annual Diversity, Equity And Inclusion (DEI) Transparency Report which provides a transparent look into its corporate culture through a DEI-focused lens. This year’s report provides an overview of Prime’s progress since 2018 and examines year-over-year improvement, acknowledging the enduring journey ahead.

Releasing this report aligns with Prime’s vision for diversity and inclusion efforts to be seen, heard and felt throughout the company, becoming part of its organizational DNA.

The report provides a clear look at Prime’s organizational makeup and highlights the milestones of the Prime Together Foundation, Diversity & Inclusion Council and employee resource groups. Additionally, it gives insight into various initiatives such as health and pay equity and Prime’s Beyond the Yellow Ribbon (BTYR) designation, awarded for its support of military employees and their families.

Erin Feigal

Specific accomplishments include:

  • Scoring 90 out of 100 on the Disability Equality Index®
  • Signing the “CEOs are IN” commitment for disability inclusion
  • Publishing gender transition resources for leaders and transitioning employees
  • Expanding DEI-related learning and training experiences for employees
  • Updating copy style guidelines to be more inclusive

“At Prime, we believe in the importance of transparency. We are proud of the progress we have made over the last few years with diversity, equity and inclusion,” said Erin Feigal, senior vice president and chief human resources officer for Prime. “While there is still work to be done, we are committed to driving progress to ensure we make positive strides on our DEI journey.”

DEI Transparency Report Highlights

Forty-two percent of Prime’s workforce identifies as one of the following: American Indian or Alaska Native (0.9%), Asian (13.3%), Black or African American (12.5%), Hispanic or Latino (6.8%), Native Hawaiian or Other Pacific Islander (0.4%), Two or More Races (3%), or Other (5.1%); 57.9% identify as White.

Prime saw an increase from 2021 in the following categories:

  • 7% increase (162% growth) in Black or African American leadership representation
  • 2% increase (134% growth) in Two or More Races representation
  • 6% increase (50% growth) in Asian leadership representation
  • 1% increase (49% growth) in Black or African American representation
  • 9% increase (5% growth) in female leadership

Review in detail the 2022 DEI Transparency Report to better understand Prime’s progress and ongoing DEI initiatives.

Related news

Stories

July 22, 2024

Introducing the latest issue of our medical and pharmacy benefit management report

The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care

Stories

July 18, 2024

Specialty drug trend forecasted to drop for employer groups, clinical experts say

Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend

Stories

July 16, 2024

Prime/Magellan Rx earns top score on the Disability Equality Index

For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion